Literature DB >> 26879140

A novel sgRNA selection system for CRISPR-Cas9 in mammalian cells.

Haiwei Zhang1, Xixi Zhang1, Cunxian Fan1, Qun Xie2, Chengxian Xu1, Qun Zhao1, Yongbo Liu1, Xiaoxia Wu1, Haibing Zhang3.   

Abstract

CRISPR-Cas9 mediated genome editing system has been developed as a powerful tool for elucidating the function of genes through genetic engineering in multiple cells and organisms. This system takes advantage of a single guide RNA (sgRNA) to direct the Cas9 endonuclease to a specific DNA site to generate mutant alleles. Since the targeting efficiency of sgRNAs to distinct DNA loci can vary widely, there remains a need for a rapid, simple and efficient sgRNA selection method to overcome this limitation of the CRISPR-Cas9 system. Here we report a novel system to select sgRNA with high efficacy for DNA sequence modification by a luciferase assay. Using this sgRNAs selection system, we further demonstrated successful examples of one sgRNA for generating one gene knockout cell lines where the targeted genes are shown to be functionally defective. This system provides a potential application to optimize the sgRNAs in different species and to generate a powerful CRISPR-Cas9 genome-wide screening system with minimum amounts of sgRNAs.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR/Cas9; Cell death; Gene knockout; Necroptosis; sgRNA selection

Mesh:

Substances:

Year:  2016        PMID: 26879140     DOI: 10.1016/j.bbrc.2016.02.041

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Recent advances of genome editing and related technologies in China.

Authors:  Wen Sun; Haoyi Wang
Journal:  Gene Ther       Date:  2020-08-03       Impact factor: 5.250

2.  Highly efficient multiplex genetic engineering of porcine primary fetal fibroblasts.

Authors:  Benjamin Klapholz; Heather Levy; Ramesh Kumbha; Nora Hosny; Michael E D'Angelo; Bernhard J Hering; Christopher Burlak
Journal:  Surg Open Sci       Date:  2020-11-18

3.  Target DNA mutagenesis-based fluorescence assessment of off-target activity of the CRISPR-Cas9 system.

Authors:  Dan Wang; Cuili Niu; Jingxin Han; Dejun Ma; Zhen Xi
Journal:  RSC Adv       Date:  2019-03-19       Impact factor: 3.361

4.  A surrogate reporter system for multiplexable evaluation of CRISPR/Cas9 in targeted mutagenesis.

Authors:  Hongmin Zhang; Yuexin Zhou; Yinan Wang; Yige Zhao; Yeting Qiu; Xinyi Zhang; Di Yue; Zhuo Zhou; Wensheng Wei
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.